{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:02Z","timestamp":1787022422464,"version":"build-2736575974"},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"1","funder":[{"name":"Basic Applied Research in Yunnan Province Yunnan","award":["2017FE468(-173)"],"award-info":[{"award-number":["2017FE468(-173)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0008","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T18:10:22Z","timestamp":1729707022000},"page":"79-91","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress"],"prefix":"10.1507","volume":"72","author":[{"given":"Ju","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingchun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Li W, Alazawi W (2020) Non-alcoholic fatty liver disease. Clin Med (Lond) 20: 509\u2013512.","DOI":"10.7861\/clinmed.2020-0696"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Wang FS, Fan JG, Zhang Z, Gao B, Wang HY (2014) The global burden of liver disease: The major impact of China. Hepatology 60: 2099\u20132108.","DOI":"10.1002\/hep.27406"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bertot LC, Adams LA (2016) The natural course of non-alcoholic fatty liver disease. Int J Mol Sci 17: 774.","DOI":"10.3390\/ijms17050774"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, et al. (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51: 595\u2013602.","DOI":"10.1002\/hep.23314"},{"key":"5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"5 Simon TG, Roelstraete B, Khalili H, Hagstrom H, Ludvigsson JF (2021) Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 70: 1375\u20131382.","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Liu Z, Lin C, Suo C, Zhao R, Jin L, et al. (2022) Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism 127: 154955.","DOI":"10.1016\/j.metabol.2021.154955"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, et al. (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972\u20131978.","DOI":"10.1002\/hep.23527"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, et al. (2012) Landscape of transcription in human cells. Nature 489: 101\u2013108.","DOI":"10.1038\/nature11233"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chen LL (2016) The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol 17: 205\u2013211.","DOI":"10.1038\/nrm.2015.32"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Han B, Chao J, Yao H (2018) Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther 187: 31\u201344.","DOI":"10.1016\/j.pharmthera.2018.01.010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Wilusz J (2018) A 360\u00b0 view of circular RNAs: From biogenesis to functions. Wiley Interdiscip Rev RNA 9: e1478.","DOI":"10.1002\/wrna.1478"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Abu N, Jamal R (2016) Circular RNAs as promising biomarkers: a mini-review. Front Physiol 7: 355.","DOI":"10.3389\/fphys.2016.00355"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Yao T, Chen Q, Fu L, Guo J (2017) Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases. Hepatol Res 47: 497\u2013504.","DOI":"10.1111\/hepr.12871"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Guo X, Sun F, Chen J, Wang Y, Pan Q, et al. (2018) circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World J Gastroenterol 24: 323\u2013337.","DOI":"10.3748\/wjg.v24.i3.323"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Guo X, Chen J, Sun F, Wang Y, Pan Q, et al. (2017) circRNA_0046367 prevents hepatoxicity of lipid peroxidation: an inhibitory role against hepatic steatosis. Oxid Med Cell Longev 2017: 3960197.","DOI":"10.1155\/2017\/3960197"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Li P, Shan K, Liu Y, Zhang Y, Xu L, et al. (2019) CircScd1 promotes fatty liver disease <i>via<\/i> the janus kinase 2\/signal transducer and activator of transcription 5 pathway. Dig Dis Sci 64: 113\u2013122.","DOI":"10.1007\/s10620-018-5290-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Chen X, Xu Y, Zhao D, Chen T, Gu C, et al. (2018) LncRNA-AK012226 is involved in fat accumulation in db\/db mice fatty liver and non-alcoholic fatty liver disease cell model. Front Pharmacol 9: 888.","DOI":"10.3389\/fphar.2018.00888"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Wei J, Qin L, Fu Y, Dai Y, Wen Y, et al. (2022) Long-term consumption of alcohol exacerbates neural lesions by destroying the functional integrity of the blood-brain barrier. Drug Chem Toxicol 45: 231\u2013238.","DOI":"10.1080\/01480545.2019.1681444"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Cai Q, Chen F, Xu F, Wang K, Zhang K, et al. (2020) Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease <i>via<\/i> integrin \u03b18-mediated activation of RhoA signaling pathway. Metabolism 104: 154140.","DOI":"10.1016\/j.metabol.2020.154140"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol 70: 531\u2013544.","DOI":"10.1016\/j.jhep.2018.10.033"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zaiou M (2019) Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases. Adv Exp Med Biol 1134: 177\u2013191.","DOI":"10.1007\/978-3-030-12668-1_10"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Wang T, Pan W, Hu J, Zhang Z, Li G, et al. (2018) Circular RNAs in metabolic diseases. Adv Exp Med Biol 1087: 275\u2013285.","DOI":"10.1007\/978-981-13-1426-1_22"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Chien Y, Tsai PH, Lai YH, Lu KH, Liu CY, et al. (2020) CircularRNA as novel biomarkers in liver diseases. J Chin Med Assoc 83: 15\u201317.","DOI":"10.1097\/JCMA.0000000000000230"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Maurice J, Manousou P (2018) Non-alcoholic fatty liver disease. Clin Med (Lond) 18: 245\u2013250.","DOI":"10.7861\/clinmedicine.18-3-245"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Cobbina E, Akhlaghi F (2017) Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 49: 197\u2013211.","DOI":"10.1080\/03602532.2017.1293683"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, et al. (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46: 823\u2013830.","DOI":"10.1002\/hep.21752"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27 Persico M, Capasso M, Persico E, Svelto M, Russo R, et al. (2007) Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 46: 1009\u20131015.","DOI":"10.1002\/hep.21782"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Bell M, Wang H, Chen H, McLenithan JC, Gong DW, et al. (2008) Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57: 2037\u20132045.","DOI":"10.2337\/db07-1383"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Schlaepfer IR, Joshi M (2020) CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology 161: bqz046.","DOI":"10.1210\/endocr\/bqz046"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Anderson CM, Stahl A (2013) SLC27 fatty acid transport proteins. Mol Aspects Med 34: 516\u2013528.","DOI":"10.1016\/j.mam.2012.07.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Black PN, Ahowesso C, Montefusco D, Saini N, DiRusso CC (2016) Fatty acid transport proteins: targeting FATP2 as a gatekeeper involved in the transport of exogenous fatty acids. Medchemcomm 7: 612\u2013622.","DOI":"10.1039\/C6MD00043F"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Liao J, Guan Y, Chen W, Shi C, Yao D, et al. (2019) ACBD3 is required for FAPP2 transferring glucosylceramide through maintaining the Golgi integrity. J Mol Cell Biol 11: 107\u2013117.","DOI":"10.1093\/jmcb\/mjy030"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Oishi Y, Spann NJ, Link VM, Muse ED, Strid T, et al. (2017) SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism. Cell Metab 25: 412\u2013427.","DOI":"10.1016\/j.cmet.2016.11.009"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Park M, Yoo JH, Lee YS, Lee HJ (2019) Lonicera caerulea extract attenuates non-alcoholic fatty liver disease in free fatty acid-induced HepG2 hepatocytes and in high fat diet-fed mice. Nutrients 11: 494.","DOI":"10.3390\/nu11030494"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Li R, Jiang J, Shi H, Qian H, Zhang X, et al. (2020) CircRNA: a rising star in gastric cancer. Cell Mol Life Sci 77: 1661\u20131680.","DOI":"10.1007\/s00018-019-03345-5"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Meng S, Zhou H, Feng Z, Xu Z, Tang Y, et al. (2017) CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer 16: 94.","DOI":"10.1186\/s12943-017-0663-2"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37 Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL (2018) CircRNA: a novel type of biomarker for cancer. Breast Cancer 25: 1\u20137.","DOI":"10.1007\/s12282-017-0793-9"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Yang W, Zhao J, Zhao Y, Li W, Zhao L, et al. (2020) Hsa_circ_0048179 attenuates free fatty acid-induced steatosis <i>via<\/i> hsa_circ_0048179\/miR-188-3p\/GPX4 signaling. Aging 12: 23996\u201324008.","DOI":"10.18632\/aging.104081"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Du WW, Fang L, Yang W, Wu N, Awan FM, et al. (2017) Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ 24: 357\u2013370.","DOI":"10.1038\/cdd.2016.133"},{"key":"40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"40 Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, et al. (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19: 141\u2013157.","journal-title":"RNA","ISSN":"https:\/\/id.crossref.org\/issn\/1355-8382","issn-type":"print"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Xiao T, Meng W, Jin Z, Wang J, Deng J, et al. (2022) miR-182-5p promotes hepatocyte-stellate cell crosstalk to facilitate liver regeneration. Commun Biol 5: 771.","DOI":"10.1038\/s42003-022-03714-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Liang Q, Chen H, Xu X, Jiang W (2019) miR-182-5p attenuates high-fat-diet-induced nonalcoholic steatohepatitis in mice. Ann Hepatol 18: 116\u2013125.","DOI":"10.5604\/01.3001.0012.7902"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Qin SB, Peng DY, Lu JM, Ke ZP (2018) MiR-182-5p inhibited oxidative stress and apoptosis triggered by oxidized low-density lipoprotein <i>via<\/i> targeting toll-like receptor 4. J Cell Physiol 233: 6630\u20136637.","DOI":"10.1002\/jcp.26389"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Liu C, Xu X, Huang C, Zhang L, Shang D, et al. (2020) Circ_002664\/miR-182-5p\/Herpud1 pathway importantly contributes to OGD\/R-induced neuronal cell apoptosis. Mol Cell Probes 53: 101585.","DOI":"10.1016\/j.mcp.2020.101585"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Sang Y, Chen B, Song X, Li Y, Liang Y, et al. (2019) circRNA_0025202 regulates tamoxifen sensitivity and tumor progression <i>via<\/i> regulating the miR-182-5p\/FOXO3a axis in breast cancer. Mol Ther 27: 1638\u20131652.","DOI":"10.1016\/j.ymthe.2019.05.011"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Zhang X, Chen W, Guo D, Li Y, Zhao Y, et al. (2022) Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p\/STARD13 regulatory axis. Biol Proced Online 24: 14.","DOI":"10.1186\/s12575-022-00176-w"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47 Mao W, Zhang Z (2024) The Hsa_circ_0105558\/miR-182-5p\/ATF6 cascade affects H(2)O(2)-triggered oxidative damage and apoptosis of human lens epithelial cells. Biochem Genet doi: 10.1007\/s10528-024-10753-1. Online ahead of print.","DOI":"10.1007\/s10528-024-10753-1"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:35:10Z","timestamp":1736548510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0008","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0008"}}